Enanta Pharmaceuticals, Inc.
Isoxazole analogs as FXR agonists and methods of use thereof
Last updated:
Abstract:
The present invention provides compounds of Formula (I), ##STR00001## and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Status:
Grant
Type:
Utility
Filling date:
12 Dec 2018
Issue date:
23 Jun 2020